Nu-Med Plus (NUMD) Net Income towards Common Stockholders (2012 - 2026)
Nu-Med Plus (NUMD) recorded Net Income towards Common Stockholders of $19,670 in Q2 2026, compared with -$11,665 a year earlier.
Powered by 
Analysis
Nu-Med Plus (NUMD) Net Income towards Common Stockholders (2012 - 2026) Analysis & Trends
On a TTM basis, Nu-Med Plus' Net Income towards Common Stockholders came in at -$16,579 as of Jun 30, 2026; for FY2025, it came in at -$56,182.
- Across earlier years, Net Income towards Common Stockholders came in at -$68,345 in FY2024, -$125,526 in FY2023, -$130,167 in FY2022 and -$830,061 in FY2021.
- The Q2 2026 figure is the highest quarterly Net Income towards Common Stockholders since Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 242.18 Bn | 221.33 Bn | 4.88 Bn | 1.74 Bn |
| 2 | Abbott Laboratories | 168.71 Bn | 139.79 Bn | 7.27 Bn | 928.00 Mn |
| 3 | Danaher | 150.46 Bn | 134.27 Bn | 3.61 Bn | 870.00 Mn |
| 4 | Intuitive Surgical | 138.71 Bn | 118.26 Bn | 1.96 Bn | 818.10 Mn |
| 5 | Medtronic | 110.54 Bn | 76.41 Bn | 6.34 Bn | 1.47 Bn |
| 6 | Stryker | 105.66 Bn | 91.78 Bn | 4.50 Bn | 1.28 Bn |
| 7 | Boston Scientific | 61.74 Bn | 56.75 Bn | 3.85 Bn | 907.00 Mn |
| 8 | Edwards Lifesciences | 49.09 Bn | 33.21 Bn | 1.35 Bn | 241.90 Mn |
| 9 | Becton Dickinson | 48.16 Bn | 45.31 Bn | 2.32 Bn | 377.00 Mn |
| 10 | Nu-Med Plus | 835,484.67 | 826,603.67 | - | 19,670.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19,670.00 |
| Dec 31, 2025 | -12,618.00 |
| Sep 30, 2025 | -11,966.00 |
| Jun 30, 2025 | -11,665.00 |
| Mar 31, 2025 | -19,933.00 |
| Dec 31, 2024 | -10,555.00 |
| Sep 30, 2024 | -18,677.00 |
| Jun 30, 2024 | -17,287.00 |
| Mar 31, 2024 | -21,826.00 |
| Dec 31, 2023 | -56,596.00 |
| Sep 30, 2023 | -16,406.00 |
| Jun 30, 2023 | -24,320.00 |
| Mar 31, 2023 | -28,204.00 |
| Dec 31, 2022 | 42,606.00 |
| Sep 30, 2022 | -58,050.00 |
| Jun 30, 2022 | -58,070.00 |
| Mar 31, 2022 | -56,653.00 |
| Dec 31, 2021 | -112,341.00 |
| Sep 30, 2021 | -118,366.00 |
| Jun 30, 2021 | -242,606.00 |
API Access
Nu-Med Plus Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=NUMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "NUMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=NUMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();